This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ding, Y. Articles by Vaziri, N. D. Search for Related Content PubMed PubMed Citation Articles by Ding, Y. Articles by Vaziri, N. D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE

(Hypertension. 1998;32:718-723.)
© 1998 American Heart Association, Inc.

Scientific Contributions

Calcium Channel Blockade Enhances Nitric Oxide Synthase Expression by Cultured Endothelial Cells

Yaoxian Ding; ; Nosratola D. Vaziri

From the Division of Nephrology, Department of Medicine, University of California at Irvine, Irvine, Calif.

Abstract—In a recent study, we found marked increases in nitric oxide (NO) production and endothelial and inducible NO synthase (eNOS and iNOS) expressions with calcium channel blockade in rats with chronic renal failure. This study was undertaken to determine whether enhanced NO production with calcium channel blockade is a direct effect of this therapy or a consequence of the associated hemodynamic and humoral changes. We tested the effects of a calcium channel blocker, felodipine (10^-5, 10^-6, and 10^-7 mol/L), on nitrate and nitrite (NOx) generation, Ca²⁺-dependent and -independent NOS activity, and eNOS and iNOS protein masses in proliferating and quiescent rat aortic endothelial cells in culture. Compared with vehicle alone, felodipine significantly increased NOx generation, Ca²⁺-dependent NOS activity, and eNOS protein mass in proliferating and quiescent endothelial cells. Felodipine did not modify the stimulatory action of 10% fetal calf serum on DNA synthesis (thymidine incorporation) and cell proliferation. Ca²⁺-independent NOS activity and iNOS protein expression were negligible and unaffected by calcium channel blockade. NOx production and NOS expression were greater in proliferating cells than in quiescent cells. Thus, calcium channel blockade upregulates endothelial NO production in vitro, confirming our previous in vivo study. This observation indicates that the reductions in cytosolic [Ca²⁺] and vasodilation with calcium channel blockade are not only due to inhibition of Ca²⁺ entry but also to an NO-cGMP–mediated mechanism.

Key Words: calcium channel blockers • endothelium-derived relaxing factor • nitric oxide • nitric oxide synthase • rats, inbred SHR

This article has been cited by other articles:

				P. Wohlfart, H. Xu, A. Endlich, A. Habermeier, E. I. Closs, T. Hubschle, C. Mang, H. Strobel, T. Suzuki, H. Kleinert, et al. Antiatherosclerotic Effects of Small-Molecular-Weight Compounds Enhancing Endothelial Nitric-Oxide Synthase (eNOS) Expression and Preventing eNOS Uncoupling J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 370 - 379. [Abstract] [Full Text] [PDF]

				X. Wu, Q. Zhou, L. Huang, A. Sun, K. Wang, Y. Zou, and J. Ge Ageing-exaggerated proliferation of vascular smooth muscle cells is related to attenuation of Jagged1 expression in endothelial cells Cardiovasc Res, March 1, 2008; 77(4): 800 - 808. [Abstract] [Full Text] [PDF]

				C. Bolego, A. Cignarella, P. Sanvito, V. Pelosi, F. Pellegatta, L. Puglisi, and C. Pinna The Acute Estrogenic Dilation of Rat Aorta Is Mediated Solely by Selective Estrogen Receptor-{alpha} Agonists and Is Abolished by Estrogen Deprivation J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1203 - 1208. [Abstract] [Full Text] [PDF]

				S. Olson, R. Oeckler, X. Li, L. Du, F. Traganos, X. Zhao, and T. Burke-Wolin Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L559 - L568. [Abstract] [Full Text] [PDF]

				N. D. Vaziri, Z. Ni, F. Oveisi, K. Liang, and R. Pandian Enhanced Nitric Oxide Inactivation and Protein Nitration by Reactive Oxygen Species in Renal Insufficiency Hypertension, January 1, 2002; 39(1): 135 - 141. [Abstract] [Full Text] [PDF]

				P. Krenek, S. Salomone, J. Kyselovic, M. Wibo, N. Morel, and T. Godfraind Lacidipine Prevents Endothelial Dysfunction in Salt-Loaded Stroke-Prone Hypertensive Rats Hypertension, April 1, 2001; 37(4): 1124 - 1128. [Abstract] [Full Text] [PDF]

				R. Berkels, G. Egink, T. A. Marsen, H. Bartels, R. Roesen, and W. Klaus Nifedipine Increases Endothelial Nitric Oxide Bioavailability by Antioxidative Mechanisms Hypertension, February 1, 2001; 37(2): 240 - 245. [Abstract] [Full Text] [PDF]

				Y. Ding, N. D. Vaziri, R. Coulson, V. S. Kamanna, and D. D. Roh Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E11 - E17. [Abstract] [Full Text] [PDF]

				Y. Ding and N. D. Vaziri Nifedipine and Diltiazem but Not Verapamil Up-Regulate Endothelial Nitric-Oxide Synthase Expression J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 606 - 609. [Abstract] [Full Text]

				N. D. Vaziri and X. Q. Wang cGMP-Mediated Negative-Feedback Regulation of Endothelial Nitric Oxide Synthase Expression by Nitric Oxide Hypertension, December 1, 1999; 34(6): 1237 - 1241. [Abstract] [Full Text] [PDF]

				N. D. Vaziri, Y. Ding, and Z. Ni Nitric Oxide Synthase Expression in the Course of Lead-Induced Hypertension Hypertension, October 1, 1999; 34(4): 558 - 562. [Abstract] [Full Text] [PDF]

				X. Q. Wang and N. D. Vaziri Erythropoietin Depresses Nitric Oxide Synthase Expression by Human Endothelial Cells Hypertension, March 1, 1999; 33(3): 894 - 899. [Abstract] [Full Text] [PDF]